MedTrace Logo

Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye

NCT00343473 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2024-07-01

No results posted yet for this study

Summary

The purpose of this research is to evaluate the optical coherence tomography (OCT), to image diseases of the eye. OCT may be useful for the early diagnosis and monitoring of a variety of diseases involving the eye, such as Fuch's Dystrophy (type of eye disease) and retinal damage (eye diseases in the back of the eye) due to diabetes.

Conditions

  • Fuch's Dystrophy
  • Corneal Disorders
  • Prior Surgery

Sponsors & Collaborators

Principal Investigators

  • Chaim Wollstein, MD · NYU Langone Health

  • Ian Conner, MD, PhD · University of Pittsburgh

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2019-09-12
Completion
2024-02-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00343473 on ClinicalTrials.gov